A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/48 (2006.01) A61P 3/06 (2006.01) C12N 9/64 (2006.01)
Patent
CA 2720681
Neutralizing PCSK9 variants that interact with low density lipoprotein receptor (LDLR) are described. Methods and compositions for treating disorders by administering a pharmaceutically effective amount of a neutralizing PCSK9 variant are described.
La présente invention concerne des variants neutralisants de la PCSK9 qui interagissent avec un récepteur de lipoprotéines de faible densité (LDLR). Des méthodes et des compositions permettant de traiter des troubles par administration dune quantité pharmaceutiquement efficace dun variant neutralisant de la PCSK9 sont décrites.
Jackson Simon Mark
Piper Derek Evan
Amgen Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Neutralizing proprotein convertase subtilisin kexin type 9... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neutralizing proprotein convertase subtilisin kexin type 9..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neutralizing proprotein convertase subtilisin kexin type 9... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1595267